This topic contains a solution. Click here to go to the answer

Author Question: The nurse is administering hormones to several clients. The nurse recognizes that which medication ... (Read 55 times)

theo

  • Hero Member
  • *****
  • Posts: 698
The nurse is administering hormones to several clients. The nurse recognizes that which medication order represents exaggerated response therapy?
 
  1. Insulin to a client with diabetes mellitus
  2. Vasopressin to a client with diabetes insipidus
  3. Thyroid hormone to a client with a history of Graves disease
  4. Corticosteroid to a client with lupus

Question 2

The nurse is caring for a client with hypocalcemia. In planning to meet the client's needs, the nurse would expect which alteration?
 
  1. An increased level of parathyroid hormone
  2. An increased level of serum calcium
  3. A decreased level of parathyroid hormone
  4. A decreased level of T3 and/or T4



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bubulittle310@msn.cn

  • Sr. Member
  • ****
  • Posts: 281
Answer to Question 1

Correct Answer: 4
Rationale 1: Insulin is not used in exaggerated response therapy.
Rationale 2: Vasopressin is not used in exaggerated response therapy.
Rationale 3: Thyroid hormone in this case would be used as a replacement and not for exaggerated response therapy.
Rationale 4: Exaggerated response therapy is the administration of hormones in large amounts to obtain some specific effects. Corticosteroids are given in large amounts to clients with lupus in order to decrease the inflammatory responses throughout the body.
Global Rationale: Exaggerated response therapy is the administration of hormones in large amounts to obtain some specific effects. Corticosteroids are given in large amounts to clients with lupus in order to decrease the inflammatory responses throughout the body. Insulin and vasopressin are not used in exaggerated response therapy. Thyroid hormone is given as replacement therapy.

Answer to Question 2

Correct Answer: 1
Rationale 1: Hypocalcemia is noted by the parathyroid gland, which releases parathyroid hormone, which strives to increase the calcium level back to normal via increased absorption and decreased excretion.
Rationale 2: Hypocalcemia refers to low serum calcium.
Rationale 3: There would not be a decreased level of parathyroid hormone in a client with hypocalcemia.
Rationale 4: Levels of T3 and T4 are not impacted by low serum calcium.
Global Rationale: Hypocalcemia is noted by the parathyroid gland, which releases parathyroid hormone, which strives to increase the calcium level back to normal via increased absorption and decreased excretion. Hypocalcemia refers to low serum calcium. Levels of T3 and T4 are not impacted by low serum calcium.




theo

  • Member
  • Posts: 698
Reply 2 on: Jul 23, 2018
Wow, this really help


tkempin

  • Member
  • Posts: 332
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library